Span-America Medical Systems, Inc.
Span-America Medical Systems, Inc. (SPAN) Stock Competitors & Peer Comparison
See (SPAN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Equipment & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SPAN | $29.99 | +0.00% | 0 | N/A | N/A | N/A |
| SIRO | $109.97 | +0.00% | 22B | N/A | N/A | N/A |
| HIMS | $19.38 | -7.09% | 4.3B | 38.08 | $0.51 | N/A |
| NVST | $24.60 | -4.80% | 4B | 87.84 | $0.28 | N/A |
| CON | $21.12 | -2.67% | 2.7B | 16.25 | $1.30 | +1.18% |
| BBNX | $10.76 | -6.60% | 477.6M | -5.94 | -$1.81 | N/A |
| CV | $7.51 | -0.27% | 351.8M | -15.65 | -$0.48 | N/A |
| NAKA | $0.23 | -5.75% | 85.1M | -0.16 | -$1.41 | N/A |
| KDLY | $11.30 | +1.16% | 68.1M | -15.48 | -$0.73 | N/A |
| NEUE | $6.75 | +0.00% | 60.9M | -0.38 | -$17.65 | N/A |
Stock Comparison
SPAN vs SIRO Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, SIRO has a market cap of 22B. Regarding current trading prices, SPAN is priced at $29.99, while SIRO trades at $109.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas SIRO's P/E ratio is N/A. In terms of profitability, SPAN's ROE is +0.17%, compared to SIRO's ROE of +0.14%. Regarding short-term risk, SPAN is more volatile compared to SIRO. This indicates potentially higher risk in terms of short-term price fluctuations for SPAN.Check SIRO's competition here
SPAN vs HIMS Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, HIMS has a market cap of 4.3B. Regarding current trading prices, SPAN is priced at $29.99, while HIMS trades at $19.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas HIMS's P/E ratio is 38.08. In terms of profitability, SPAN's ROE is +0.17%, compared to HIMS's ROE of +0.23%. Regarding short-term risk, SPAN is less volatile compared to HIMS. This indicates potentially lower risk in terms of short-term price fluctuations for SPAN.Check HIMS's competition here
SPAN vs NVST Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, NVST has a market cap of 4B. Regarding current trading prices, SPAN is priced at $29.99, while NVST trades at $24.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas NVST's P/E ratio is 87.84. In terms of profitability, SPAN's ROE is +0.17%, compared to NVST's ROE of +0.02%. Regarding short-term risk, SPAN is more volatile compared to NVST. This indicates potentially higher risk in terms of short-term price fluctuations for SPAN.Check NVST's competition here
SPAN vs CON Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, CON has a market cap of 2.7B. Regarding current trading prices, SPAN is priced at $29.99, while CON trades at $21.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas CON's P/E ratio is 16.25. In terms of profitability, SPAN's ROE is +0.17%, compared to CON's ROE of +0.47%. Regarding short-term risk, SPAN is more volatile compared to CON. This indicates potentially higher risk in terms of short-term price fluctuations for SPAN.Check CON's competition here
SPAN vs BBNX Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, BBNX has a market cap of 477.6M. Regarding current trading prices, SPAN is priced at $29.99, while BBNX trades at $10.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas BBNX's P/E ratio is -5.94. In terms of profitability, SPAN's ROE is +0.17%, compared to BBNX's ROE of -0.24%. Regarding short-term risk, SPAN is more volatile compared to BBNX. This indicates potentially higher risk in terms of short-term price fluctuations for SPAN.Check BBNX's competition here
SPAN vs CV Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, CV has a market cap of 351.8M. Regarding current trading prices, SPAN is priced at $29.99, while CV trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas CV's P/E ratio is -15.65. In terms of profitability, SPAN's ROE is +0.17%, compared to CV's ROE of +1.05%. Regarding short-term risk, SPAN is less volatile compared to CV. This indicates potentially lower risk in terms of short-term price fluctuations for SPAN.Check CV's competition here
SPAN vs NAKA Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, NAKA has a market cap of 85.1M. Regarding current trading prices, SPAN is priced at $29.99, while NAKA trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas NAKA's P/E ratio is -0.16. In terms of profitability, SPAN's ROE is +0.17%, compared to NAKA's ROE of -0.74%. Regarding short-term risk, SPAN is less volatile compared to NAKA. This indicates potentially lower risk in terms of short-term price fluctuations for SPAN.Check NAKA's competition here
SPAN vs KDLY Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, KDLY has a market cap of 68.1M. Regarding current trading prices, SPAN is priced at $29.99, while KDLY trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas KDLY's P/E ratio is -15.48. In terms of profitability, SPAN's ROE is +0.17%, compared to KDLY's ROE of -0.74%. Regarding short-term risk, SPAN is more volatile compared to KDLY. This indicates potentially higher risk in terms of short-term price fluctuations for SPAN.Check KDLY's competition here
SPAN vs NEUE Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, NEUE has a market cap of 60.9M. Regarding current trading prices, SPAN is priced at $29.99, while NEUE trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas NEUE's P/E ratio is -0.38. In terms of profitability, SPAN's ROE is +0.17%, compared to NEUE's ROE of +0.22%. Regarding short-term risk, SPAN is more volatile compared to NEUE. This indicates potentially higher risk in terms of short-term price fluctuations for SPAN.Check NEUE's competition here
SPAN vs PARK Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, PARK has a market cap of 31.8M. Regarding current trading prices, SPAN is priced at $29.99, while PARK trades at $16.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas PARK's P/E ratio is -90.78. In terms of profitability, SPAN's ROE is +0.17%, compared to PARK's ROE of -67.96%. Regarding short-term risk, SPAN is more volatile compared to PARK. This indicates potentially higher risk in terms of short-term price fluctuations for SPAN.Check PARK's competition here
SPAN vs BRK Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, BRK has a market cap of 11.6M. Regarding current trading prices, SPAN is priced at $29.99, while BRK trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas BRK's P/E ratio is N/A. In terms of profitability, SPAN's ROE is +0.17%, compared to BRK's ROE of N/A. Regarding short-term risk, SPAN is more volatile compared to BRK. This indicates potentially higher risk in terms of short-term price fluctuations for SPAN.Check BRK's competition here
SPAN vs PFSA Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, PFSA has a market cap of 264.3K. Regarding current trading prices, SPAN is priced at $29.99, while PFSA trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas PFSA's P/E ratio is -0.01. In terms of profitability, SPAN's ROE is +0.17%, compared to PFSA's ROE of +0.90%. Regarding short-term risk, SPAN is less volatile compared to PFSA. This indicates potentially lower risk in terms of short-term price fluctuations for SPAN.Check PFSA's competition here
SPAN vs EXAC Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, EXAC has a market cap of 0. Regarding current trading prices, SPAN is priced at $29.99, while EXAC trades at $49.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas EXAC's P/E ratio is N/A. In terms of profitability, SPAN's ROE is +0.17%, compared to EXAC's ROE of +0.00%. Regarding short-term risk, SPAN is more volatile compared to EXAC. This indicates potentially higher risk in terms of short-term price fluctuations for SPAN.Check EXAC's competition here
SPAN vs STJ Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, STJ has a market cap of 0. Regarding current trading prices, SPAN is priced at $29.99, while STJ trades at $80.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas STJ's P/E ratio is N/A. In terms of profitability, SPAN's ROE is +0.17%, compared to STJ's ROE of +0.21%. Regarding short-term risk, SPAN is more volatile compared to STJ. This indicates potentially higher risk in terms of short-term price fluctuations for SPAN.Check STJ's competition here
SPAN vs MEDC Comparison April 2026
SPAN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPAN stands at 0. In comparison, MEDC has a market cap of 0. Regarding current trading prices, SPAN is priced at $29.99, while MEDC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPAN currently has a P/E ratio of N/A, whereas MEDC's P/E ratio is N/A. In terms of profitability, SPAN's ROE is +0.17%, compared to MEDC's ROE of N/A. Regarding short-term risk, SPAN is less volatile compared to MEDC. This indicates potentially lower risk in terms of short-term price fluctuations for SPAN.Check MEDC's competition here